Kang Chen Cheng-Piao Luo De-Xiang Ge Ke-Lin Wang Qin Luo Yan-Zhi Li Xue-Mei You Bang-De Xiang Le-Qun Li Liang Ma Jian-Hong Zhong
10.3389/fonc.2022.946693
Front Oncol
2022 Oct 6;12:946693.
conversion therapy hepatocellular carcinoma immune checkpoint inhibitor transarterial chemoembolization tyrosine kinase inhibitor
CC BY
https://pubmed.ncbi.nlm.nih.gov/36276151/
Case Reports
PMC9583878
36276151
Case report: Conversion therapy to permit resection of initially unresectable hepatocellular carcinoma
2022